These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24838100)

  • 1. How to slow down septic hearts?
    Rozec B
    J Mol Cell Cardiol; 2014 Sep; 74():112-4. PubMed ID: 24838100
    [No Abstract]   [Full Text] [Related]  

  • 2. Ivabradine in heart failure: NICE guidance.
    Hardman SM
    Heart; 2014 Jan; 100(2):93-5. PubMed ID: 23781111
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial protection in sepsis.
    Shakar S; Lowes BD
    Crit Care; 2008; 12(5):177. PubMed ID: 18828869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional management of inappropriate sinus tachycardia.
    Olshansky B; Sullivan RM
    J Interv Card Electrophysiol; 2016 Jun; 46(1):43-5. PubMed ID: 26164138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resting heart rate as prognostic parameter--a slow rate indicates strength].
    Füessl HS
    MMW Fortschr Med; 2008 May; 150(21):12-4, 16. PubMed ID: 18575247
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscular bridge causing non-ST-segment elevation myocardial infarction.
    Aytan P; Ulusal G; Yenigün EC; Yildirim O; Pirpir A; Yildirim S
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):374-5. PubMed ID: 17162289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart failure].
    Merx MW; Ertl G
    Dtsch Med Wochenschr; 2011 Apr; 136(14):700-2. PubMed ID: 21448830
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease, another funny aspect of the funny channel?
    van der Hoeven NW; van Royen N
    Heart; 2014 Jan; 100(2):98-9. PubMed ID: 24381297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heart rate control in patients with sepsis and septic cardiomyopathy: the role of Ivabradine].
    Shen Z; Zhou Z; Fang H; Zhang Y; Wang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1393-1398. PubMed ID: 33463505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding ivabradine may reduce elevated heart rate in acute patients when β blockers are ineffective.
    Trivi M; Forti L; Conde D; Diez M
    Am J Emerg Med; 2014 May; 32(5):471-2. PubMed ID: 24581885
    [No Abstract]   [Full Text] [Related]  

  • 12. CrossTalk opposing view: bradycardia in the trained athlete is attributable to a downregulation of a pacemaker channel in the sinus node.
    D'Souza A; Sharma S; Boyett MR
    J Physiol; 2015 Apr; 593(8):1749-51. PubMed ID: 25871551
    [No Abstract]   [Full Text] [Related]  

  • 13. Ivabradine versus bisoprolol.
    Fazio G; Sarulo F; Licata P; D'Angelo L; Passantino S; Visconti C; Zarcone P; Spanò C; Novo G; Novo S
    Minerva Cardioangiol; 2010 Apr; 58(2):281-2. PubMed ID: 20440257
    [No Abstract]   [Full Text] [Related]  

  • 14. [Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
    MMW Fortschr Med; 2014 Nov; 156(20):75. PubMed ID: 25543378
    [No Abstract]   [Full Text] [Related]  

  • 15. How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?
    Borer JS
    JACC Heart Fail; 2015 Mar; 3(3):231-3. PubMed ID: 25650367
    [No Abstract]   [Full Text] [Related]  

  • 16. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study.
    Schroeder C; Heusser K; Zoerner AA; Großhennig A; Wenzel D; May M; Sweep FC; Mehling H; Luft FC; Tank J; Jordan J
    Clin Pharmacol Ther; 2014 Jun; 95(6):601-7. PubMed ID: 24509430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT study.
    Komajda M
    Arch Cardiovasc Dis; 2011 Feb; 104(2):67-9. PubMed ID: 21402339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attaining therapy relevant goals with ivabradin].
    Lohmann M
    MMW Fortschr Med; 2014 Oct; 156(17):71. PubMed ID: 25417482
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.
    Zwicker C; Becker M; Lepper W; Koch KC; Westenfeld R
    Cardiology; 2010; 116(3):174-7. PubMed ID: 20628253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phonomecanographic study of 3 beta-blockers and d-propranolol in obstructive cardiomyopathy].
    Hitchitz S; Veyrat C; Gourtchiglouian M
    Therapie; 1978; 33(5):599-606. PubMed ID: 33466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.